7.57Open7.57Pre Close0 Volume31 Open Interest21.50Strike Price0.00Turnover0.00%IV0.59%PremiumAug 23, 2024Expiry Date7.40Intrinsic Value100Multiplier-1DDays to Expiry0.17Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma3.91Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Fomo Mofo : we all saw the webinar. for a company with 18 employees id say they are doing really well. let's hope the stock gods smile upon us on Monday with some official good news
Ken Griffin Charity2 : Why not provide the source? GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and Smallpox This press release was published 19 December 2023.
Geovax has been working on a covid vaccine for the past 4 years. There is still no approved covid vaccine, much less one for mpox.